Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominic T Moore

Showing results (11-20 of 105) with videos related to

Pageof 11
Sort By:
Cancer Investigation|February 15, 2011
Infusional mitoxantrone plus bolus melphalan as a stem cell transplant conditioning regimen for multiple myelomaAnne W Beaven, Dominic T Moore, Andrew Sharf, et al.
Molecular Pharmacology|September 28, 2004
Evidence that mitogen-activated protein kinase phosphatase-1 induction by proteasome inhibitors plays an antiapoptotic roleGeorge W Small, Yue Y Shi, Natalie A Edmund, et al.
International Journal of Radiation Oncology, Biology, Physics|June 30, 2009
Radiosensitization of chemotherapy-refractory, locally advanced or locally recurrent breast cancer with trastuzumab: a phase II trialJanet K Horton, Jan Halle, Madlyn Ferraro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2003
Overexpression of focal adhesion kinase in primary colorectal carcinomas and colorectal liver metastases: immunohistochemistry and real-time PCR analysesAmy L Lark, Chad A Livasy, Benjamin Calvo, et al.
The Oncologist|January 25, 2015
A randomized phase II study of carboplatin with weekly or every-3-week nanoparticle albumin-bound paclitaxel (abraxane) in patients with extensive-stage small cell lung cancerJuneko E Grilley-Olson, Vicki L Keedy, Alan Sandler, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 21, 2015
Endometrial Cancer Survivors' Perceptions of Provider Obesity Counseling and Attempted Behavior Change: Are We Seizing the Moment?Leslie H Clark, Emily M Ko, Amber Kernodle, et al.
Neurosurgery|October 1, 2013
The volumetric response of brain metastases after stereotactic radiosurgery and its post-treatment implicationsSuzanne R Sharpton, Eric K Oermann, Dominic T Moore, et al.
The Journal of Urology|May 6, 2004
Racial differences in prostate androgen levels in men with clinically localized prostate cancerJames L Mohler, Kris E Gaston, Dominic T Moore, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 2, 2013
A retrospective analysis of VeriStrat status on outcome of a randomized phase II trial of first-line therapy with gemcitabine, erlotinib, or the combination in elderly patients (age 70 years or older) with stage IIIB/IV non-small-cell lung cancerThomas E Stinchcombe, Joanna Roder, Amy H Peterman, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 13, 2005
Phenotypic evaluation of the basal-like subtype of invasive breast carcinomaChad A Livasy, Gamze Karaca, Rita Nanda, et al.
Pageof 11

Showing results (11-20 of 105) with videos related to

Sort By:
Pageof 11
Cancer Investigation|February 15, 2011
Infusional mitoxantrone plus bolus melphalan as a stem cell transplant conditioning regimen for multiple myelomaAnne W Beaven, Dominic T Moore, Andrew Sharf, et al.
Molecular Pharmacology|September 28, 2004
Evidence that mitogen-activated protein kinase phosphatase-1 induction by proteasome inhibitors plays an antiapoptotic roleGeorge W Small, Yue Y Shi, Natalie A Edmund, et al.
International Journal of Radiation Oncology, Biology, Physics|June 30, 2009
Radiosensitization of chemotherapy-refractory, locally advanced or locally recurrent breast cancer with trastuzumab: a phase II trialJanet K Horton, Jan Halle, Madlyn Ferraro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2003
Overexpression of focal adhesion kinase in primary colorectal carcinomas and colorectal liver metastases: immunohistochemistry and real-time PCR analysesAmy L Lark, Chad A Livasy, Benjamin Calvo, et al.
The Oncologist|January 25, 2015
A randomized phase II study of carboplatin with weekly or every-3-week nanoparticle albumin-bound paclitaxel (abraxane) in patients with extensive-stage small cell lung cancerJuneko E Grilley-Olson, Vicki L Keedy, Alan Sandler, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 21, 2015
Endometrial Cancer Survivors' Perceptions of Provider Obesity Counseling and Attempted Behavior Change: Are We Seizing the Moment?Leslie H Clark, Emily M Ko, Amber Kernodle, et al.
Neurosurgery|October 1, 2013
The volumetric response of brain metastases after stereotactic radiosurgery and its post-treatment implicationsSuzanne R Sharpton, Eric K Oermann, Dominic T Moore, et al.
The Journal of Urology|May 6, 2004
Racial differences in prostate androgen levels in men with clinically localized prostate cancerJames L Mohler, Kris E Gaston, Dominic T Moore, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 2, 2013
A retrospective analysis of VeriStrat status on outcome of a randomized phase II trial of first-line therapy with gemcitabine, erlotinib, or the combination in elderly patients (age 70 years or older) with stage IIIB/IV non-small-cell lung cancerThomas E Stinchcombe, Joanna Roder, Amy H Peterman, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 13, 2005
Phenotypic evaluation of the basal-like subtype of invasive breast carcinomaChad A Livasy, Gamze Karaca, Rita Nanda, et al.
Pageof 11